In the face of chronic disease, DTx have the opportunity to provide a lifeline to patients.
Joel Morse
Advertisement
CEO, Curavit Clinical Research
Articles by Joel Morse
How DCTs can impact pharmaceutical companies exploring DTx combination products and standalone DTx studies.
Advertisement
Latest Updated Articles
How Healthcare Economics Outcomes Evidence Can Pave the Way for Digital TherapeuticsPublished: December 21st 2023 | Updated:
Digital Therapeutics and Decentralized Trials: A Match Made in ClinicalPublished: April 13th 2022 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
2
2025 SCRS Global Site Solutions Summit: How Technology Vendors Can Reduce Site Burden and Improve Trial Execution
3
2025 SCRS Global Site Solutions Summit: How to Streamline Site Qualification and Initiation Training
4
AI in Action: Breaking Down Clinical Trial Bottlenecks
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
